BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Advarra - ECPv6.15.12.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Advarra
X-ORIGINAL-URL:https://www.advarra.com
X-WR-CALDESC:Events for Advarra
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251215T130000
DTEND;TZID=America/New_York:20251215T140000
DTSTAMP:20260409T230504
CREATED:20251203T030128Z
LAST-MODIFIED:20251203T030250Z
UID:66920-1765803600-1765807200@www.advarra.com
SUMMARY:Mastering Inspection Readiness for FDA’s AI Tool Elsa
DESCRIPTION:Mastering Inspection Readiness for FDA’s AI Tool Elsa
URL:https://www.advarra.com/event/mastering-inspection-readiness-for-fdas-ai-tool-elsa/
CATEGORIES:Third-Party Webinars,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251016T110000
DTEND;TZID=America/New_York:20251016T120000
DTSTAMP:20260409T230504
CREATED:20250922T161059Z
LAST-MODIFIED:20250922T161103Z
UID:65822-1760612400-1760616000@www.advarra.com
SUMMARY:Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research
DESCRIPTION:Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research\n\n\n\n\n\n\n\n\nAs part of Oncology Research Pulse\, our new thought leadership initiative designed to foster collaboration that advances oncology research\, we’re partnering with Fierce Pharma to explore how to overcome administrative and operational barriers in clinical research.  \n\n\n\n\n\nOncology research sites are under growing pressure. Trial protocols are more and more complex\, administrative demands are increasing\, and staffing remains a persistent challenge. These issues slow study start-up\, limit patient access\, and strain the teams responsible for delivering research.  \n\n\n\n In this webinar\, leaders from cancer centers and biopharma companies will discuss the operational and institutional hurdles sites face and what can be done to address them. The panel will explore practical strategies to reduce burden\, improve collaboration\, and create a better experience for research staff and patients alike. \n\n\n\n\n\nKey Takeaways\n\n\n\n\nThe most pressing administrative and operational challenges facing oncology sites\n\n\n\nHow cancer centers are working to streamline processes and improve site capacity\n\n\n\nWhat sponsors can do to reduce site burden and better align with oncology research site needs\n\n\n\nWays to improve the day-to-day experience for site staff without compromising quality\n\n\n\nWhy enabling site success is essential to expanding access and accelerating research\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\nSean CunninghamRegional Director\, Americas – Study Site EngagementTakeda Pharmaceuticals \n\n\n\n\n\nMeredith HightowerDirector\, Strategic Site Partnerships\, Clinical Field Excellence\, CSMAbbVie \n\n\n\nSara MoelleringDirector of Clinical Research OperationsUniversity of Chicago \n\n\n\nSara RaboinPhDDirector of Operations Yale Cancer Center \n\n\n\nChristine SennSenior Vice President\, Head of Site-Sponsor InnovationAdvarra
URL:https://www.advarra.com/event/enabling-oncology-site-success-overcoming-administrative-and-operational-barriers-to-advance-cancer-research/
CATEGORIES:Third-Party Webinars,Webinar
ATTACH;FMTTYPE=image/png:https://www.advarra.com/wp-content/uploads/Fierce-Pharma-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250807T120000
DTEND;TZID=America/New_York:20250807T120000
DTSTAMP:20260409T230504
CREATED:20250814T221801Z
LAST-MODIFIED:20250814T222221Z
UID:65379-1754568000-1754568000@www.advarra.com
SUMMARY:Improving Clinical Tech Adoption: Site-Centric Approaches
DESCRIPTION:Improving Clinical Tech Adoption: Site-Centric Approaches\n\n\n\n\n\n\n\n\nSponsors invest heavily in study technology to drive efficiency and oversight\, but adoption at the site level often lags\, stalling the very benefits these systems promise. This webinar offers a unique opportunity for sponsors and CROs to hear directly from site professionals and sponsor peers who navigate and implement sponsor-deployed technologies every day. Through real-world perspectives\, this webinar will explore what helps — or hinders — site adoption\, and how sponsors can better evaluate\, implement and support study systems with site success in mind. \n\n\n\nJoin the featured speakers to: \n\n\n\n\nHear candid perspectives from site professionals on the real challenges of adopting sponsor-deployed technology\n\n\n\nLearn how sponsor-CRO collaboration can directly influence technology success at the site level\n\n\n\nUnderstand what makes study systems more intuitive — and what leads to frustration or failure\n\n\n\nRegister now to explore how study technology can be optimized for real-world site adoption and long-term success.\n\n\n\n\n\n\nKey Takeaways\n\n\n\nAttendees will gain insights to: \n\n\n\n\nIdentify and address the key barriers that prevent sites from adopting sponsor-deployed study technologies\n\n\n\nApply proven strategies to evaluate\, implement and support study systems with site usability and efficiency in mind\n\n\n\nFacilitate and incorporate direct site feedback to refine technology rollouts and improve long-term adoption and engagement
URL:https://www.advarra.com/event/from-ethics-to-evidence-applying-real-world-data-in-oncology-trials-2/
CATEGORIES:Third-Party Webinars,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250623T130000
DTEND;TZID=America/New_York:20250623T140000
DTSTAMP:20260409T230504
CREATED:20250603T162926Z
LAST-MODIFIED:20250603T165739Z
UID:64566-1750683600-1750687200@www.advarra.com
SUMMARY:From Ethics to Evidence: Applying Real-World Data in Oncology Trials
DESCRIPTION:From Ethics to Evidence: Applying Real-World Data in Oncology Trials\n\n\n\n\n\n\n\n\nAs part of Oncology Research Pulse\, our new thought leadership initiative designed to foster collaboration that advances oncology research\, we’re partnering with Fierce Pharma to explore how to ethically and effectively incorporate RWD into oncology clinical research. \n\n\n\n\n\nReal-world data (RWD) is a powerful asset for pharmaceutical sponsors looking to enhance oncology trial design\, support regulatory submissions\, and demonstrate real-world value. From generating external control arms to identifying patient cohorts and uncovering long-term safety signals\, RWD offers strategic advantages across the development lifecycle. But as the stakes grow\, so does the ethical responsibility to use RWD with transparency\, fairness\, and patient-centered rigor.This webinar will explore how to ethically and effectively incorporate RWD into oncology clinical research. Industry leaders and experts will share insights on navigating consent\, bias\, and data provenance—while aligning with regulatory expectations and building confidence in research practices. \n\n\n\n\n\nKey Takeaways\n\n\n\n\nHow RWD can be used to improve oncology clinical trial design and operations\n\n\n\nEthical considerations around patient privacy\, informed consent\, and data provenance—and strategies to align scientific\, ethical\, and reputational goals in trial design\n\n\n\nFDA\, EMA\, and global guidance on the responsible use of RWD\n\n\n\nDesigned for R&D\, clinical strategy\, and regulatory leaders\, this session offers a practical framework for building responsible\, high-impact RWD programs in oncology research.\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\nSean CunninghamRegional Director\, Americas – Study Site EngagementTakeda Pharmaceuticals \n\n\n\n\n\nMeredith HightowerDirector\, Strategic Site Partnerships\, Clinical Field Excellence\, CSMAbbVie \n\n\n\nSara MoelleringDirector of Clinical Research OperationsUniversity of Chicago \n\n\n\nSara RaboinPhDDirector of Operations Yale Cancer Center
URL:https://www.advarra.com/event/from-ethics-to-evidence-applying-real-world-data-in-oncology-trials/
CATEGORIES:Third-Party Webinars,Webinar
ATTACH;FMTTYPE=image/png:https://www.advarra.com/wp-content/uploads/Fierce-Pharma-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250415T120000
DTEND;TZID=America/New_York:20250415T130000
DTSTAMP:20260409T230504
CREATED:20250227T203616Z
LAST-MODIFIED:20250227T204526Z
UID:62721-1744718400-1744722000@www.advarra.com
SUMMARY:Accelerating Study Start-Up to Improve Research Site Success
DESCRIPTION:Timelines for study start-up affect everything from budgets and drug pricing to a site’s ability to secure trials. This webinar will provide actionable strategies to streamline start-up processes\, accelerate regulatory approvals\, and optimize patient recruitment. By adopting these best practices\, sites can reduce delays\, improve trial timelines\, and strengthen their competitive edge. \n\n\n\nLearning Objectives: \n\n\n\n\nDiscuss the importance of start-up speed in clinical research and its direct impact on trial timelines and success.\n\n\n\nIntegrate insights into actionable strategies and best practices to accelerate start-up processes and streamline regulatory approvals.\n\n\n\nReview tactics to leverage accelerated start-up phases to enhance efficiency\, minimize delays\, and optimize patient recruitment.\n\n\n\n\n\n\n\n\nFeaturing\n\n\n\nChristine SennSenior Vice President\, Site-Sponsor Innovation\, Advarra
URL:https://www.advarra.com/event/accelerating-study-start-up-to-improve-research-site-success/
LOCATION:Virtual
CATEGORIES:Third-Party Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.advarra.com/wp-content/uploads/scrs_webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250410T130000
DTEND;TZID=America/New_York:20250410T140000
DTSTAMP:20260409T230504
CREATED:20250327T162239Z
LAST-MODIFIED:20250327T163251Z
UID:63520-1744290000-1744293600@www.advarra.com
SUMMARY:Making Just-in-Time Oncology Trials Work: Overcoming Barriers and Unlocking Potential
DESCRIPTION:Making Just-in-Time Oncology Trials Work: Overcoming Barriers and Unlocking Potential\n\n\n\n\n\n\n\n    \n\n\n\nAs part of Oncology Research Pulse\, our new thought leadership initiative designed to foster collaboration that advances cancer research\, we’re partnering with Fierce Pharma to explore how just-in-time (JIT) oncology trials can accelerate research\, reduce costs\, and expand patient access to cutting-edge treatments.  \n\n\n\nLearning Objectives: \n\n\n\n\nAccelerating patient access through data-driven pre-screening and site partnerships \n\n\n\nOptimizing sponsor-site-IRB collaboration for seamless trial activation \n\n\n\nOvercoming operational hurdles with pre-negotiated agreements and standardized processes \n\n\n\nBalancing speed and quality in real-world JIT oncology trials \n\n\n\n\nFeaturing\n\n\n\nChristine SennSenior Vice President\, Site-Sponsor Innovation\, Advarra
URL:https://www.advarra.com/event/making-oncology-trials-work/
CATEGORIES:Third-Party Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.advarra.com/wp-content/uploads/1742490323176-e1743092528809.jpg
END:VEVENT
END:VCALENDAR